期刊文献+

2015—2019年腹腔积液标本病原菌分布及抗菌药物耐药性分析 被引量:1

Distribution of pathogens and antimicrobial resistance in ascites samples from 2015 to 2019
下载PDF
导出
摘要 目的分析2015—2019年云南省第二人民医院住院患者腹腔积液标本病原菌分布及抗菌药物耐药性,指导临床合理选用抗菌药物。方法回顾性分析本院2015—2019年收集的腹腔积液标本(1254份)分离的病原菌分布及药敏试验结果。结果1254份腹腔积液标本共分离出非重复病原菌687株,总检出率为54.78%,在687株病原菌中主要是革兰阴性菌,最常见的是大肠埃希菌和肺炎克雷伯菌,其次是以屎肠球菌和表皮葡萄球菌为主的革兰阳性菌;真菌占10.19%,最多见的是白色念珠菌。革兰阴性菌检出率由2016年的79.82%下降至2019年的53.21%,呈现明显下降趋势(P<0.05),革兰阳性菌检出率由2016年的20.18%上升至2019年的46.79%,呈现明显上升趋势(P<0.05)。科室主要来源于普通外科,占61.3%、ICU占23.8%。产超广谱β-内酰胺酶(ESBLs)大肠埃希菌和肺炎克雷伯菌的检出率分别为64.09%、43.48%,产ESBLs的大肠埃希菌和肺炎克雷伯菌对青霉素类、第一代和第三代头孢菌素耐药率均在90%以上,大肠埃希菌和肺炎克雷伯菌对碳青霉烯类耐药率不超过50%,但不产ESBLs的肺炎克雷伯菌相比产ESBLs的肺炎克雷伯菌对碳青霉烯类抗生素反而耐药率偏高。结论革兰阴性菌是本院腹腔积液标本分离的主要病原菌,尤其是产ESBLs的大肠埃希菌和肺炎克雷伯菌检出率高,而且产ESBLs容易出现假阴性现象,可能与同时产碳青霉烯酶有关,产ESBLs对常见抗菌药物耐药率均有较高耐药率,合理选用抗菌药物的同时也要加强耐药菌株的监测,防止院内感染暴发流行。 Objective To analyze the distribution of pathogenic bacteria and antimicrobial resistance in peritoneal effusion samples of hospitalized patients in the Second People’s Hospital of Yunnan Province from 2015 to 2019,and to guide clinical rational use of antimicrobial agents.Methods The results of pathogenic bacteria distribution and in vitro drug sensitivity test of ascites specimen(1254 cases)collected in our hospital from 2015 to December 2019 were retrospectively analyzed.Results 687 strains of non repetitive pathogens were isolated from 1254 samples of ascites,the total detection rate was 54.78%.Among the 687 strains of pathogens,the most common were Escherichia coli and Klebsiella pneumoniae,followed by Enterococcus faecium and Staphylococcus epidermidis;fungi accounted for 10.19%,the most common was Candida albicans.The detection rate of Gram-negative bacteria decreased from 79.82%in 2016 to 53.21%in 2019,showing a significant downward trend(P<0.05),and the detection rate of Gram-positive bacteria increased from 20.18%in 2016 to 46.79%in 2019,showing a significant upward trend(P<0.05).61.3%of the departments came from general surgery and 23.8%from ICU.The detection rates of ESBLs producing Escherichia coli and Klebsiella pneumoniae were 64.09%and 43.48%respectively.The resistance rates of ESBLs producing Escherichia coli and Klebsiella pneumoniae to penicillins,the first and third generation cephalosporins were more than 90%.The resistance rates of Escherichia coli and Klebsiella pneumoniae to carbapenems were less than 50%,but the resistance rates of non ESBLs producing Klebsiella pneumoniae were higher than those of ESBLs producing Klebsiella pneumoniae.On the contrary,the drug resistance rate of Klebsiella pneumoniae to carbapenems was higher.Conclusion Gram negative bacteria are the main pathogens isolated from peritoneal effusion samples in our hospital,especially ESBLs producing Escherichia coli and Klebsiella pneumoniae,and ESBLs producing bacteria are prone to false negative phenomenon.Laboratory staff should pay high attention to the high drug resistance rate of ESBLs producing bacteria to common antibiotics,and reasonable selection of antibiotics.At the same time,we should strengthen the monitoring of drug-resistant strains to prevent the outbreak of nosocomial infection.
作者 郭媛媛 邓德耀 宋健梅 袁文丽 徐红云 吕红玲 顾津伊 徐佳丽 GUO Yuanyuan;DENG Deyao;SONG Jianmei(Department of Clinical Laboratory,Fourth Affiliated Hospital of Kunming Medical University/the Second People's Hospital of Yunnan Province,Kunming 650000,China)
出处 《临床合理用药杂志》 2021年第18期1-4,8,共5页 Chinese Journal of Clinical Rational Drug Use
基金 云南省科技厅应用基础研究联合专项基金资助项目(2015FB081) 云南省应用基础研究计划基金资助项目(2011FZ289) 昆明医科大学研究生创新基金资助项目(2019S202)。
关键词 抗菌药 腹腔积液 病原菌 耐药性 Anti-bacterial agents Ascites Pathogenic bacteria Drug resistance
  • 相关文献

参考文献16

二级参考文献121

  • 1裴保香,罗燕萍,王睿.环丙沙星使用量与大肠埃希菌对其他抗菌药物耐药性的相关性研究[J].中华医院感染学杂志,2005,15(10):1166-1168. 被引量:31
  • 2张嵘,周宏伟,陈功祥,周铁丽.应用MRSA ID产色琼脂培养基等四种方法检测和鉴定耐甲氧西林金黄色葡萄球菌[J].中华检验医学杂志,2007,30(4):388-391. 被引量:5
  • 3梁力建,郑惊雷.胆道感染的抗生素选择与合理应用[J].中国现代普通外科进展,2007,10(2):117-120. 被引量:17
  • 4Augustin P, Kermarrec N, Muller-Serieys C, et al. Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis [J]. Crit Care, 2010, 14 (1): R20. DOI: 10.1186/cc8877.
  • 5Lopez N, Kobayashi L, Coimbra R. A Comprehensive review of abdominal infections [J]. World J Emerg Surg, 2011, 6 : 7. DOI: 10.1186/1749-7922-6-7.
  • 6Montravers P, Dupont H, Leone M, et al. Guidelines for management of intra-abdominal infections [J]. Anaesth Crit Care Pain Med, 2015, 34 (2): 117-130. DOI: lO.lO16/j.accpm.2015.03.005.
  • 7Sartelli M, Viale P, Catena F, et al. 2013 WSES guidelines for management of intra-abdominal infections [J]. World J Emerg Surg, 2013, 8 (1): 3. DOI: 10.1186/1749-7922-8-3.
  • 8Sartelli M, Catena F, Coccolini F, et al. Antimicrobial management of intra-abdominal infections: literature's guidelines [J]. World J Gastroenterol, 2012, 18 (9): 865-871. DOI: lO.3748/wjg.v18.i9.865.
  • 9Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America [J]. Clin Infect Dis, 2010, 50 (2): 133-164. DOI: 10.1086/649554.
  • 10Borer A, Saidel-Odes L, Riesenberg K, et al. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia [J]. Infect Control Hosp Epidemiol, 2009, 30 (10): 972-976. DOI: 10.1086/605922.

共引文献320

同被引文献16

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部